Numinus Wellness Inc. (NUMIF)
OTCMKTS · Delayed Price · Currency is USD
0.0210
-0.0010 (-4.55%)
Sep 16, 2026, 11:26 AM EST
Numinus Wellness Income Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 6.85 | 7.65 | 4.29 | 3.75 | 6.49 | 1.51 | |
Revenue Growth | 3.64% | 78.25% | 14.43% | -42.21% | 329.03% | 71.78% |
Cost of Revenue | 3.21 | 3.84 | 3 | 2.16 | 4.72 | 1.6 |
Gross Profit | 3.65 | 3.82 | 1.29 | 1.59 | 1.78 | -0.08 |
Selling, General & Admin | 4.47 | 6.97 | 11.79 | 20.09 | 23.91 | 12.09 |
Research & Development | - | - | 0.03 | 1.17 | 1.89 | 1.4 |
Operating Expenses | 4.77 | 7.44 | 13.09 | 24.05 | 30.23 | 15.76 |
Operating Income | -1.12 | -3.62 | -11.8 | -22.46 | -28.45 | -15.84 |
Interest Expense | -0.1 | -0.16 | -0.1 | -0.17 | -0.56 | -0.11 |
Interest & Investment Income | 0.01 | 0.02 | 0.01 | 0 | 0 | - |
Currency Exchange Gain (Loss) | 0.01 | -0 | -0.06 | -0.07 | 0.21 | - |
Other Non Operating Income (Expenses) | 0.21 | -0.34 | 0.11 | -0.28 | 0.01 | -0.02 |
EBT Excluding Unusual Items | -1 | -4.11 | -11.85 | -22.98 | -28.78 | -15.98 |
Merger & Restructuring Charges | - | - | - | - | -2.52 | -0.27 |
Impairment of Goodwill | - | - | - | - | -13.23 | -1.58 |
Gain (Loss) on Sale of Investments | - | - | -1.23 | - | - | - |
Gain (Loss) on Sale of Assets | 7.48 | - | -0.93 | -0.25 | - | - |
Asset Writedown | -0.64 | -0.64 | -0.17 | - | -0.37 | -0.9 |
Other Unusual Items | - | - | -0.3 | -0.01 | -0.02 | -0.05 |
Pretax Income | 5.84 | -4.75 | -14.48 | -23.24 | -44.92 | -18.77 |
Income Tax Expense | 0.42 | 0.42 | - | - | -0.03 | - |
Earnings From Continuing Operations | 5.42 | -5.16 | -14.48 | -23.24 | -44.88 | -18.77 |
Earnings From Discontinued Operations | 1.57 | 1.72 | -5.14 | -7.02 | - | - |
Net Income | 6.99 | -3.44 | -19.62 | -30.26 | -44.88 | -18.77 |
Net Income to Common | 6.99 | -3.44 | -19.62 | -30.26 | -44.88 | -18.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 296 | 295 | 295 | 264 | 217 | 165 |
Shares Outstanding (Diluted) | 296 | 295 | 295 | 264 | 217 | 165 |
Shares Change | -6.11% | - | 11.95% | 21.72% | 31.31% | 158.48% |
EPS (Basic) | 0.02 | -0.01 | -0.07 | -0.11 | -0.21 | -0.11 |
EPS (Diluted) | 0.02 | -0.01 | -0.07 | -0.11 | -0.21 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Free Cash Flow | 1.28 | -1.74 | -12.46 | -22.99 | -27.48 | -16.22 |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.04 | -0.09 | -0.13 | -0.10 |
Gross Margin | 53.20% | 49.88% | 30.09% | 42.45% | 27.36% | -5.39% |
Operating Margin | -16.41% | -47.36% | -274.82% | -598.39% | -438.10% | -1046.54% |
Profit Margin | 102.07% | -44.97% | -456.89% | -806.23% | -691.12% | -1240.29% |
Free Cash Flow Margin | 18.66% | -22.79% | -290.11% | -612.67% | -423.09% | -1071.59% |
EBITDA | -1.19 | -3.48 | -11.16 | -21.46 | -27.88 | -15.47 |
EBITDA Margin | -17.41% | -45.49% | -259.96% | - | - | - |
D&A For EBITDA | -0.07 | 0.14 | 0.64 | 0.99 | 0.57 | 0.37 |
EBIT | -1.12 | -3.62 | -11.8 | -22.46 | -28.45 | -15.84 |
EBIT Margin | -16.41% | -47.36% | -274.82% | - | - | - |